Market Closed -
Borsa Italiana
11:44:59 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
92.02
EUR
|
-0.11%
|
|
-3.03%
|
-1.31%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,315
|
9,289
|
9,163
|
6,962
|
4,969
|
4,911
|
-
|
-
|
Enterprise Value (EV)
1 |
6,142
|
8,984
|
10,149
|
7,868
|
5,745
|
5,588
|
5,433
|
5,244
|
P/E ratio
|
36.1
x
|
37.5
x
|
31
x
|
31.4
x
|
32.5
x
|
28.7
x
|
24.1
x
|
20.5
x
|
Yield
|
0.82%
|
0.59%
|
0.63%
|
0.84%
|
1.24%
|
1.02%
|
1.14%
|
1.24%
|
Capitalization / Revenue
|
8.94
x
|
10.5
x
|
7.4
x
|
5.11
x
|
4.33
x
|
4.16
x
|
3.85
x
|
3.58
x
|
EV / Revenue
|
8.7
x
|
10.2
x
|
8.2
x
|
5.78
x
|
5
x
|
4.73
x
|
4.26
x
|
3.82
x
|
EV / EBITDA
|
22.2
x
|
23.3
x
|
18.7
x
|
15.3
x
|
15.3
x
|
14.6
x
|
12.7
x
|
11
x
|
EV / FCF
|
34.1
x
|
38.8
x
|
33.7
x
|
24.9
x
|
29
x
|
26.3
x
|
22.8
x
|
19
x
|
FCF Yield
|
2.93%
|
2.58%
|
2.96%
|
4.02%
|
3.45%
|
3.8%
|
4.38%
|
5.27%
|
Price to Book
|
7.61
x
|
9.74
x
|
6.71
x
|
4.56
x
|
3.23
x
|
2.92
x
|
2.74
x
|
2.77
x
|
Nbr of stocks (in thousands)
|
54,723
|
54,608
|
54,719
|
53,388
|
53,289
|
53,365
|
-
|
-
|
Reference price
2 |
115.4
|
170.1
|
167.4
|
130.4
|
93.24
|
92.02
|
92.02
|
92.02
|
Announcement Date
|
3/11/20
|
3/11/21
|
3/16/22
|
3/27/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
706.3
|
881.3
|
1,238
|
1,361
|
1,148
|
1,181
|
1,274
|
1,373
|
EBITDA
1 |
276.8
|
385.3
|
543.1
|
514.2
|
375
|
382.9
|
428.3
|
477.9
|
EBIT
1 |
217.9
|
324.2
|
465.1
|
417
|
283
|
268.5
|
312
|
357.2
|
Operating Margin
|
30.85%
|
36.79%
|
37.58%
|
30.64%
|
24.65%
|
22.74%
|
24.49%
|
26.02%
|
Earnings before Tax (EBT)
1 |
216.3
|
321.4
|
399.3
|
325.9
|
201
|
229
|
284.7
|
327.1
|
Net income
1 |
175.7
|
248.3
|
310.7
|
240.1
|
159
|
185.8
|
217.9
|
248.9
|
Net margin
|
24.88%
|
28.17%
|
25.1%
|
17.64%
|
13.85%
|
15.74%
|
17.1%
|
18.13%
|
EPS
2 |
3.200
|
4.534
|
5.400
|
4.150
|
2.870
|
3.212
|
3.821
|
4.494
|
Free Cash Flow
1 |
180.1
|
231.6
|
300.7
|
316
|
198.4
|
212.3
|
237.8
|
276.1
|
FCF margin
|
25.5%
|
26.28%
|
24.3%
|
23.22%
|
17.28%
|
17.98%
|
18.66%
|
20.11%
|
FCF Conversion (EBITDA)
|
65.07%
|
60.11%
|
55.37%
|
61.45%
|
52.91%
|
55.45%
|
55.51%
|
57.78%
|
FCF Conversion (Net income)
|
102.5%
|
93.27%
|
96.78%
|
131.61%
|
124.79%
|
114.24%
|
109.14%
|
110.94%
|
Dividend per Share
2 |
0.9500
|
1.000
|
1.050
|
1.100
|
1.158
|
0.9411
|
1.045
|
1.142
|
Announcement Date
|
3/11/20
|
3/11/21
|
3/16/22
|
3/27/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
356
|
382.3
|
515.4
|
343.5
|
378.8
|
357.6
|
327.8
|
685.4
|
326.8
|
348.8
|
289.6
|
286.8
|
576.4
|
270
|
302
|
276.1
|
329.1
|
317.6
|
282.3
|
256.2
|
EBITDA
1 |
-
|
153.6
|
244.2
|
139.2
|
159.9
|
149.8
|
119.3
|
269.1
|
122.1
|
123
|
97.5
|
92.5
|
190
|
88
|
97
|
93.07
|
97.61
|
97.64
|
108.3
|
-
|
EBIT
1 |
-
|
123.6
|
201.9
|
112.2
|
151
|
126.2
|
95.17
|
221.4
|
97.3
|
98.3
|
74.8
|
69.6
|
144.4
|
-
|
74
|
63.03
|
75.33
|
74.34
|
65.84
|
65.94
|
Operating Margin
|
-
|
32.33%
|
39.17%
|
32.66%
|
39.86%
|
35.29%
|
29.03%
|
32.3%
|
29.77%
|
28.18%
|
25.83%
|
24.27%
|
25.05%
|
-
|
24.5%
|
22.83%
|
22.89%
|
23.41%
|
23.33%
|
25.74%
|
Earnings before Tax (EBT)
1 |
-
|
122.2
|
196.1
|
103.6
|
99.5
|
106.2
|
75.58
|
181.8
|
80.1
|
64
|
54.5
|
-
|
-
|
-
|
56
|
54
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
94.7
|
150
|
79.3
|
81.4
|
82.3
|
58.51
|
140.8
|
62.1
|
37.2
|
41.7
|
45.1
|
86.9
|
-
|
47
|
46.08
|
50.33
|
47.91
|
58.23
|
-
|
Net margin
|
-
|
24.77%
|
29.1%
|
23.09%
|
21.49%
|
23.01%
|
17.85%
|
20.54%
|
19%
|
10.67%
|
14.4%
|
15.73%
|
15.08%
|
-
|
15.56%
|
16.69%
|
15.29%
|
15.08%
|
20.63%
|
-
|
EPS
2 |
-
|
-
|
-
|
-
|
1.490
|
1.470
|
1.090
|
-
|
1.150
|
-
|
-
|
-
|
-
|
-
|
-
|
0.7571
|
0.9108
|
0.8874
|
0.8302
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.2397
|
0.3596
|
0.3596
|
0.2397
|
0.2509
|
Announcement Date
|
3/11/20
|
7/30/20
|
7/30/21
|
11/11/21
|
3/16/22
|
5/6/22
|
8/3/22
|
8/3/22
|
10/27/22
|
3/27/23
|
5/9/23
|
7/27/23
|
7/27/23
|
11/3/23
|
3/15/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
986
|
907
|
776
|
677
|
522
|
333
|
Net Cash position
1 |
173
|
305
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.815
x
|
1.763
x
|
2.07
x
|
1.769
x
|
1.219
x
|
0.6968
x
|
Free Cash Flow
1 |
180
|
232
|
301
|
316
|
198
|
212
|
238
|
276
|
ROE (net income / shareholders' equity)
|
22.6%
|
27.5%
|
26.7%
|
16.6%
|
10.5%
|
12.5%
|
13.1%
|
13.7%
|
ROA (Net income/ Total Assets)
|
-
|
21.5%
|
15.9%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
1,157
|
1,949
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
15.20
|
17.50
|
25.00
|
28.60
|
28.80
|
31.50
|
33.60
|
33.20
|
Cash Flow per Share
2 |
4.250
|
5.560
|
7.010
|
6.740
|
5.590
|
5.670
|
6.050
|
6.840
|
Capex
1 |
52.2
|
73
|
117
|
114
|
113
|
107
|
106
|
109
|
Capex / Sales
|
7.39%
|
8.28%
|
9.48%
|
8.35%
|
9.86%
|
9.1%
|
8.29%
|
7.95%
|
Announcement Date
|
3/11/20
|
3/11/21
|
3/16/22
|
3/27/23
|
3/15/24
|
-
|
-
|
-
|
Last Close Price
92.02
EUR Average target price
97.41
EUR Spread / Average Target +5.86% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.31% | 5.29B | | -1.89% | 12.56B | | -9.59% | 7.68B | | +21.82% | 5.18B | | +0.02% | 4.57B | | -50.89% | 3.29B | | +6.42% | 2.6B | | -10.02% | 2.2B | | -8.29% | 1.79B | | +1.72% | 1.76B |
Diagnostic & Testing Substances
|